|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000021484 |
| Receipt No. | R000024781 |
| Scientific Title | Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy in locally advanced pancreatic ductal adenocarcinoma |
| Date of disclosure of the study information | 2016/04/01 |
| Last modified on | 2020/11/20 12:24:02 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2016/03/15 21:51:13 | ||
| 2 | Update | 2016/09/09 20:41:57 | Recruitment status |
|
| 3 | Update | 2018/09/17 15:00:03 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Name of primary sponsor Organization |
|
| 4 | Update | 2020/11/20 12:21:38 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Email3 Organization Organization Address Address Tel |
|
| 5 | Update | 2020/11/20 12:24:02 | Key secondary outcomes |
